Items tagged with Access
WHO issues Information Note on ensuring continuity of essential TB services for people with or at risk of the disease in Ukraine and refugee-hosting countries (post)
19 May 2022 | Geneva: The World Health Organization (WHO) is working closely with Ukraine, countries hosting refugees, affected populations and partners to rapidly respond to the humanitarian crisis caused by war and minimize disruptions to the delivery of critical health care services. As part of these overarching efforts, WHO is working to enable access to tuberculosis (TB) care services for all people with or at risk of TB within Ukraine and in refugee-hosting countries.
U.S. Government funded research brings shorter TB treatment regimens to New York City (post)
May 16, 2022 – We applaud the New York City Department of Health and Mental Hygiene (DoHMH) for its leadership as one of the first TB programs in the U.S. and globally to introduce a new four-month regimen for the treatment of drug-susceptible tuberculosis (TB). This new regimen represents a long-awaited breakthrough, offering a shorter alternative to the six-to-nine-month treatment in use since the 1980s. That the Department of Health and Mental Hygiene is moving forward to make this regimen available to patients will make treatment more tolerable for people living with TB. As TB survivor and activist Kate O’Brien of We Are TB and co-chair of the TB Roundtable put it, “TB treatment can be such a miserable experience, with all sorts of side effects and logistical complications. Shorter regimens offer patients welcome relief and I’m thrilled to see important government investments delivering better cures for TB.”
Shorter TB treatment shows promise in Nigeria (post)
-- Nigeria is one of eight countries that accounts for two-thirds of new TB cases
-- A new six-month treatment for TB is being considered for rollout nationwide
-- The WHO-recommended regimen could help combat drug resistance
Drug makers must address access to antibiotics to help slow the superbug threat (post)
New report sets out six case studies of drug makers that are increasing local access to antibiotics and antifungals, including through technology transfers and partnerships. People in low- and middle-income countries cannot get the antibiotics and antifungal medicines they need. This is fuelling the spread of drug resistance.
South Africa: Shorter, simpler DR-TB regimen expected later this year (post)
Work is underway in South Africa to amend the country’s national guidelines for drug-resistant TB to provide a shorter, six-month, all-oral regimen as a new standard of care treatment.
Regulatory best practices for global access to medicines, including TB medicines (post)
The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) will conduct a three half-days conference Regulatory Best Practices for Global Access to Medicines, Including Anti-TB Medicines on 16-18 August 2022.
‘Patients are falling through the cracks’: drug costs hinder India’s response to TB (post)
The country has the world’s largest number of multi-drug-resistant cases – but doctors and activists warn patients are going undiagnosed and untreated.
TB affects more men globally — but women feel more of a social impact (post)
When it comes to tuberculosis (TB), men and boys bear the highest disease burden, accounting for 64% of all TB cases in 2020. But this single statistic does not capture the full impact of the disease.
Prevention and treatment of infectious diseases in migrants in Europe in the era of universal health coverage (post)
Summary
Lupin partners with global agencies to increase patient access to TB prevention treatment (post)
Makes rifapentine-based treatment available at an affordable price to support TB prevention in low-and middle-income countries
Page 47 of 83 · Total posts: 0
←First 46 47 48 Last→